NIH-funded research U01 cooperative agreement

Sleep data that predict opioid treatment outcomes

Official title: Value of Sleep Metrics in Predicting Opioid-Use Disorder Treatment Outcomes: Leadership and Data Coordinating Center

Funded at Harvard Pilgrim Health Care, INC. · NIH-11398231 · Data updated 2026-11-12

A big multi-site study will look at sleep and circadian patterns to help predict how well people with opioid-use disorder do when on standard treatments.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionHarvard Pilgrim Health Care, INC.
NIH-funded
Lab location1 site (Canton, UNITED STATES)
Project startSeptember 30, 2023
Project endAugust 31, 2027
Funding year2026
Award (this year)$678,723
NIH project number5U01DA059472-04
Project IDNIH-11398231 on NIH RePORTER

Who could benefit from this research

Could help

Adults with opioid-use disorder enrolled in MOUD programs who consent to sleep monitoring and data sharing.

Less likely to help

Patients without sleep disturbances or those not participating in long-term MOUD follow-up may see limited benefit.

What this research studies

This project will bring together experts in sleep science and addiction medicine to collect and analyze sleep metrics from people receiving MOUD across multiple sites. It will use data coordination and centralized leadership to identify which sleep patterns are linked to staying in treatment and better outcomes. The goal is to uncover sleep-related markers that could guide personalized care in OUD treatment.

Why it matters

Potential benefit: If successful, patients may receive more tailored treatment plans that consider sleep health, potentially improving retention and outcomes in MOUD.

How similar studies have gone: Previous research shows sleep problems predict treatment dropout, but this study aims to clarify which sleep measures are most predictive in early recovery.

Where this research is happening

  • Harvard Pilgrim Health Care, INC.
    Canton, United States
    Active

Researchers

  • Principal investigator: Wang, Rui — Harvard Pilgrim Health Care, INC.
  • Study coordinator: Wang, Rui

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.